September 2015 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for September 2015. This roundup includes...
Strategies Provided for Improving EHR Efficiency
Tips include educating staff about preferences and processes, using own templates to reduce editing
Angioedema Induced by New Classes of Drugs
Angioedema occurs with DPP IV or neprilysin blockers; bradykinin contribution seems likely
Negative Spiritual Belief Linked to Worse Health Outcomes
Link seen for individuals with heterogeneous health conditions, regardless of positive spiritual beliefs
Nocturnal Hypoglycemia Linked to Reduced Awakening Response
Rate of awakenings significantly lower during hypoglycemic versus normoglycemic night
Calcium Supplements May Not Benefit Bone Health
Researchers find no evidence that increasing intake will prevent fractures
Gene Variant May Boost Effect of Higher-Protein Diet in T2DM
Researchers find benefit for those with gene variant related to vitamin D metabolism
More Support for High-Fiber, Mediterranean Diet
Beneficial effects for plant-based diet but not limited to vegetarian or vegan diets
FDA Approves Two New Medications for Diabetes
Tresiba and Ryzodeg approved for use in adults with type 1 and 2 diabetes mellitus
Fidgeting Offers Health Benefits to Sedentary Women
Fidgeting may mediate some of the negative effects of prolonged sitting, British study contends
